Laryngomedin N (Hexamidine Diisetionate)

Hexamidine diisetionate is a cationic antiseptic that binds to negatively charged components of microbial cell membranes. This interaction disrupts membrane integrity, causing leakage of intracellular contents and rapid cell death. Its broad‑spectrum activity covers Gram‑positive and Gram‑negative bacteria as well as fungi, providing a non‑systemic antimicrobial effect in the oropharyngeal cavity.

The appropriate dose of Laryngomedin N is determined by a qualified healthcare professional based on the specific indication, patient age, and clinical condition. Because the product is available without a prescription, patients should follow the dosing instructions provided on the label or those given by a pharmacist or physician.

Safety data for hexamidine diisetionate in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using Laryngomedin N to weigh potential benefits against any unknown risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Laryngomedin N. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Compared with chlorhexidine‑based mouthwashes, hexamidine diisetionate offers a similar broad‑spectrum antimicrobial effect but is generally associated with a lower incidence of tooth staining. It also provides rapid symptom relief for sore throat and is well tolerated when used as directed, making it a suitable alternative for patients seeking an OTC option.

Laryngomedin N should be stored at room temperature, ideally below 25 °C, in its original container. Keep the product away from direct sunlight, moisture and heat sources. Ensure the cap is tightly closed after each use to maintain product stability and prevent contamination.

The product is applied topically to the oral cavity and throat. Typically, a measured amount is swished or gargled for the time indicated on the label, then expectorated. It should not be swallowed in large quantities. Users should avoid eating or drinking for a short period after application to allow optimal contact time.

While most reactions are mild, serious adverse events can include anaphylaxis, Stevens‑Johnson syndrome, severe oral ulceration, and persistent dysphagia. Any signs of severe allergic reaction—such as difficulty breathing, swelling of the face or throat, or widespread rash—require immediate medical attention.

Individuals with a known hypersensitivity to hexamidine diisetionate or any component of the formulation should avoid using Laryngomedin N. It is also not recommended for children younger than two years of age, and patients with severe oral mucosal lesions should seek professional advice before use.